Key facts
- Samsara BioCapital is a venture capital firm based in Palo Alto, California with 38 tracked portfolio companies.
- Notable positions include Parabilis Medicines, Delfi Diagnostics, Abcuro, Candid Therapeutics, SpyGlass Pharma (NAS: SGP).
- Samsara BioCapital has 1 fund on record, raising $310.1M across the 1 that report a size.
- Samsara BioCapital reports $242.9M in regulatory assets under management across 3 private funds, per its SEC Form ADV (2026-03).
About Samsara BioCapital
Founded in 2016, Samsara BioCapital is a venture capital investment firm based in Palo Alto, California. The firm prefers to invest in the healthcare sector across the United States. This firm is a Registered Investment Adviser (RIA).
Registered with the SEC
Form ADV · 2026-03 · CRD 288114- Regulatory AUM
- $242.9M
- Private fund assets
- $2.3B
- Private funds
- 3 · 3 venture
- Staff
- 31
- Registered office
- —
- SEC status
- Approved
Reports custody of client assets.
Source: SEC Investment Adviser Public Disclosure, Form ADV (registered as SAMSARA BIOCAPITAL, LLC).
Free account
See the whole book
- ·The book's top 25 — of 38 recorded positions
- ·Watchlist + alerts for Samsara BioCapital's activity
Create free account
No card required
Portfolio, priced
38 companies · by our current valuations| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| Parabilis Medicines | Drug Discovery | $920.0M | — | |
| Delfi Diagnostics | — | $725.0M | — | |
| Abcuro | Drug Discovery | $700.0M | — | |
| Candid Therapeutics | Drug Discovery | $657.0M | — | |
| SpyGlass Pharma (NAS: SGP) | Surgical Devices | $510.6M | — | |
| Dewpoint Therapeutics | — | $500.0M | — | |
| Synthekine | — | $500.0M | — | |
| Egenesis | — | $330.0M | — | |
| OrsoBio | — | $310.0M | — | |
| Enlaza Therapeutics | — | $295.0M | — | |
| Pathalys Pharma | — | $295.0M | — | |
| A2 Bio | — | $280.0M | — | |
| Ottimo Pharma | — | $242.4M | — | |
| Autobahn Therapeutics | — | $218.0M | — | |
| EpiBiologics | — | $210.0M | — | |
| + 23 more companies · a free account shows the top of the book | ||||
Funds
1 recorded- Samsara BioCapital, L.P.2017$310.1M
$310.1M raised across the 1 fund that report a size
Frequently asked
- What companies does Samsara BioCapital invest in?
- Samsara BioCapital has 38 recorded portfolio companies, including Parabilis Medicines, Delfi Diagnostics, Abcuro, Candid Therapeutics.
- What is Samsara BioCapital's AUM?
- Samsara BioCapital manages approximately $1.9B in assets.